Borel & Barbey advised NeuroGyn AG on a CHF 3 mio financing round
Borel & Barbey recently advised NeuroGyn AG in a successful CHF 3 million financing round led by a business angel. Founded by Prof. Dr. Marc Possover, NeuroGyn AG is a…
Neuropelveology, the story of 30 years of Pioneering
Neuropelveology – The Story of 30 Years of Pioneering The field of neuropelveology was pioneered by Professor Marc Possover, a gynecological surgeon based in Switzerland. In the early 2000s. He…
Hypersensitivity of the bladder
HYPERSENSITIVITY OF THE BLADDER The hypersensitivity of the bladder should not be confused with OAB (Overactive Bladder) Summary Bladder hypersensitivity is a complex and often underdiagnosed condition that significantly impacts…
NeuroGyn Revolutionizes Pelvic Neuromodulation with Groundbreaking Clinical Study – June 2023
Link here In a groundbreaking clinical study, published as peer-review in the Journal of Minimally Invasive Gynecology in 2023 – the official Journal of the American Association of Gynecological Laparoscopists…
Neurogyn Secures Groundbreaking Patents in Pelvic Neuromodulation – October 2022
Neurogyn Secures Groundbreaking Patents in Pelvic Neuromodulation In a significant stride towards revolutionizing the field of pelvic neuromodulation, Neurogyn AG, the leading medical technology company in the field of neuropelveology,…
Imec And NeuroGyn AG Collaborate On Advanced Neurostimulation Device For Pelvic Nerve Disorders
Imec 01.10.22 Link: click here Imec is developing a next-generation implantable device for peripheral nerve stimulation together with NeuroGyn AG, a Swiss medtech company specialized in neurostimulaton and surgical solutions for pelvic…
Die „Pudendal LION Prozedure“ zur Behandlung der Reizblase
Die "Pudendal LION Prozedure" zur Behandlung der Reizblase Die "Pudendal LION Prozedure" zur Behandlung der Reizblase findet Anerkennung in der USA und wird in "The Journal of Minimal Invasive Gynecology"…
NeuroGyn AG – Gewinner des „Swiss Technology Award 2014 – Kategorie „Inventors“
NeuroGyn AG – Gewinner des „Swiss Technology Award 2014 – Kategorie „Inventors“ Die Ansätze in der Becken-Neuromodulation reichen von der Behandlung von Schmerzen und Blasen-/Darmentleerungsstörungen (Inkontinenz, Reizblase) bis zur Wiederherstellung…